In a recent publication from Wang et al., the genetic polymorphism of SETD2 in adult AML patients was evaluated for survival outcome and SETD2 rs76208147 TT genotype performed better in overall survival.34 The gene discussed is SETD2; the disease is acute myeloid leukemia.